Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.
about
Transjugular intrahepatic portosystemic shunts for hepatorenal syndromeTerlipressin for hepatorenal syndromeResponse to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 hModulation of splanchnic circulation: Role in perioperative management of liver transplant patientsHepatorenal syndrome: Update on diagnosis and treatmentRenal failure in cirrhosis: Emerging conceptsHuman albumin in the management of complications of liver cirrhosisTreatment and management of ascites and hepatorenal syndrome: an updateThe conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosisProtecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Cirrhosis and its complications: evidence based treatment.Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy StudyCurrent concepts in the diagnosis and classification of renal dysfunction in cirrhosis.Renal dysfunction in patients with cirrhosis: Where do we stand?Effect of various drugs used in conservative therapy of hepatorenal syndrome: a retrospective drug utilization studyManagement of cirrhotic ascitesPredictors of renal recovery in patients with pre-orthotopic liver transplant (OLT) renal dysfunction.A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements.New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.Role of human albumin in the management of complications of liver cirrhosis.Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis.From the nephrologist's point of view: diversity of causes and clinical features of acute kidney injuryImproving survival in decompensated cirrhosisHepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Follow-up Study.Noradrenalin versus the combination of midodrine and octreotide in patients with hepatorenal syndrome: randomized clinical trial.Therapeutic potential of targeting the renin angiotensin system in portal hypertension.Hyponatremia and Hepatorenal SyndromeCross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - RevisedPredictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1.The effect of octreotide on urine output during orthotopic liver transplantation and early postoperative renal function; a randomized, double-blind, placebo-controlled trialClinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study.Management of hepatorenal syndrome in patients with cirrhosis.Hepatorenal syndrome in the intensive care unit.Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites.Recent advances in our understanding of hepatorenal syndrome.Review article: towards a considered and ethical approach to organ support in critically-ill patients with cirrhosis.
P2860
Q24198269-FE3321DF-3BC7-447D-B10E-AC220BD93A32Q24200336-4D6F76E6-87E5-464B-BC1C-72C8388D626AQ26770382-7AF56522-0CCB-40C0-A3D8-CB6DB36A6428Q26773222-DABC14E3-8DB2-46B8-8D46-AEA3AFB83F5FQ26777608-0C1F7B2D-F90B-4102-965B-C1C1A6DBCE67Q26785971-A696F5DD-2FAC-4040-9A71-0945F884B862Q26852608-3E6D6AB0-B282-44CC-9836-B2D9A41C0FF3Q27000268-1EE75B2A-3E2E-42E2-95BC-A0CF27BBD1E6Q27009164-710C4D91-DBC5-4277-AB72-B8238A6F76F0Q30251763-ABD5BAEE-95B5-4F28-BAC9-5EC739A72788Q33594931-65957416-FA91-422B-9B9F-87AFF3692831Q33698303-A8312423-42A4-4235-A3D6-60B4F0FE5AB9Q33805260-BC73381A-E32E-4A93-9044-51F9A043E3C8Q33811643-B1E406DE-7806-4ED9-82F5-F1E5EE4974B1Q34047665-A57A6775-5D3D-4DB0-BCC7-123739B932A4Q34247676-7ECB669D-8597-4C00-B9B6-76DEDE334F7EQ34475601-87B8C1A6-A851-4E34-97BA-20894CC342B4Q34816170-C3D47925-8CD2-486F-8F03-2B730745AF7FQ34873261-C063310A-D664-40FB-A034-425FA9EB1E30Q35565646-7EC2EF91-8FBE-4051-8A01-05549B6D1234Q35574320-63E76DA8-5D4F-45BA-80C9-80C438678AF2Q35654104-7AAB1EE3-AD2C-4BC2-9AC2-FCDACF66B15EQ35852815-A8725695-ABAB-4FEC-94B4-4754D6620EB5Q35891577-3DB1E416-C22C-4F85-9559-7BF7C4AF9365Q36090423-68741A5B-45FC-4B6E-996B-E28C465AC009Q36093575-E3727082-F2BD-45B6-A159-8573D7E64A07Q36133714-ABB50ADF-AA87-4085-85AB-9EC1B5065CADQ36422621-89FFC313-21B9-4C4D-B21D-C6BCC002CB52Q36769062-C60F4800-22F4-4C92-B4E2-40B624D73F3BQ36812531-3A13E664-48A5-46E6-9E88-0A966F547801Q37045780-E3AE5C43-14B1-4E1E-9958-EC5DA80D79A3Q37058079-C6347490-7AA6-444E-95A2-BDF2CE28F3A1Q37141412-587FCFAE-2AF9-4343-AE93-FE160A3B8D2CQ37315198-06B54396-4655-4309-A040-2914001B103AQ37429032-DC3B3CD9-EE71-4206-9D23-83A9B3F77709Q37913980-57CEF38B-A8CA-46E3-987F-C94485D311C9Q37920945-C1BE47DE-317C-4FC3-A600-6CF6CDFFAF5CQ38002958-C92B9C7C-F7E2-4534-8AFF-624E64A75429Q38012022-DACE738E-9447-4FD8-848D-8F46D65CDB97Q38060261-5D9B695F-CE49-47C7-BA37-BFE344DE8941
P2860
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.
@en
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.
@nl
type
label
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.
@en
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.
@nl
prefLabel
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.
@en
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.
@nl
P2860
P356
P1433
P1476
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
@en
P2093
Erik Christensen
Kurt Christensen
P2860
P304
P356
10.1002/HEP.23286
P407
P577
2010-02-01T00:00:00Z